Table 3.
25(OH)Da | Cases | % with outcome | Unadjusted risk ratio | 95% CI | Adjustedb risk ratio | 95% CI |
---|---|---|---|---|---|---|
Primary cesarean delivery | 52 | 1.9 | ||||
<30 nmol/L | 13 | 1.9 | Reference | Reference | ||
30–49 nmol/L | 14 | 1.5 | 0.78 | 0.37 – 1.64 | 0.76 | 0.38 – 1.55 |
50–74 nmol/L | 19 | 2.5 | 1.28 | 0.64 – 2.57 | 1.22 | 0.61 – 2.44 |
≥75 nmol/L | 6 | 1.4 | 0.70 | 0.27 – 1.84 | 0.65 | 0.24 – 1.81 |
Indicated instrumental deliveryc, d | 211 | 7.6 | ||||
<30 nmol/L | 50 | 7.6 | Reference | Reference | ||
30–49 nmol/L | 63 | 6.9 | 0.91 | 0.63 – 1.31 | 0.84 | 0.57 – 1.22 |
50–74 nmol/L | 61 | 8.1 | 1.07 | 0.74 – 1.54 | 0.92 | 0.63 – 1.35 |
≥75 nmol/L | 36 | 8.4 | 1.10 | 0.72 – 1.68 | 0.88 | 0.56 – 1.39 |
Primary cesarean or indicated instrumental delivery c | 262 | 9.4 | ||||
<30 nmol/L | 63 | 9.5 | Reference | Reference | ||
30–49 nmol/L | 77 | 8.3 | 0.88 | 0.64 – 1.22 | 0.83 | 0.60 – 1.16 |
50–74 nmol/L | 80 | 10.5 | 1.11 | 0.81 – 1.52 | 1.00 | 0.72 – 1.39 |
≥75 nmol/L | 42 | 9.7 | 1.02 | 0.70 – 1.50 | 0.87 | 0.58 – 1.30 |
Note: All data based on combined results from 5 imputed datasets.
Abbreviation: 25(OH)D, 25-hydroxyvitamin D.
25(OH)D measured at ≤26 weeks gestation.
Adjusted for prepregnancy BMI, race/ethnicity, and study site (except cesarean models adjusted for latitude instead of study site). Conditional logistic regression models conditioned on study site and adjusted for prepregnancy BMI and race/ethnicity yielded similar results.
Vaginal delivery by forceps or vacuum excluding those with “elective” listed as indication.
n=2759 women who entered stage 2 labor.